53 result(s) have been found!
| Accession | Name | Sequence | Source/Organism | Mechanism | Assay Type | Cell Line | Cancer Type | Activity |
|---|---|---|---|---|---|---|---|---|
| dbacp01142 | Amphipathic peptide CT1 | MKTQFVILIVAVVLLQLISHSEAFLGALWNVAKSVFGKRGLRNFDDLDDTFEPEMSEADLKYLQDLLR | Scorpions, Morelos, located in South-Central Mexico (Mexican scorpion) | Not specified | MTT/MTS assay | MCF-7 | Breast cancer | IC50 : 6.3-12.5 μM |
| dbacp02357 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 15.5 µM |
| dbacp02358 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | BTS-30 | Breast cancer | IC50 : 24.8 µM |
| dbacp02359 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | HRT-18 | Colon cancer | IC50 : 25.5 µM |
| dbacp02360 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | DLD-1 | Colon cancer | IC50 : >100 µM |
| dbacp02361 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | WEHI-3B | Leukemia cancer | IC50 : 4.4 µM |
| dbacp02362 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | A-2780 | Ovarian cancer | IC50 : 30.6 µM |
| dbacp02363 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | HCLO | Colon cancer | IC50 : 33.5 µM |
| dbacp02364 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | CHO-KI | Ovarian cancer | IC50 : 32 µM |
| dbacp02365 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | MAC15A | Colon cancer | IC50 : 37 µM |
| dbacp02366 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | MCF-7 | Breast cancer | IC50 : 42.5 µM |
| dbacp02367 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | HT-29 | Colon cancer | IC50 : >100 µM |
| dbacp02368 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | A-2780R | Ovarian cancer | IC50 : 34.5 µM |
| dbacp02369 | Cecropin B | KWKVFKKIEKMGRNIRNGIVKAGPAIAVLGEAKAL | Silkmoth | Pore formation at the cytoplasmic membrane | MTT/MTS assay | MCF-7R | Breast cancer | IC50 : 24.5 µM |
| dbacp02371 | Cecropin P1 | SWLSKTAKKLENSAKKRISEGIAIAIQGGPR | Small Intestine of Pig | Pore formation at the cytoplasmic membrane | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 93 µM |
| dbacp02372 | Cecropin P1 | SWLSKTAKKLENSAKKRISEGIAIAIQGGPR | Small Intestine of Pig | Pore formation at the cytoplasmic membrane | MTT/MTS assay | BTS-30 | Breast cancer | IC50 : >100 µM |
| dbacp02373 | Cecropin P1 | SWLSKTAKKLENSAKKRISEGIAIAIQGGPR | Small Intestine of Pig | Pore formation at the cytoplasmic membrane | MTT/MTS assay | HRT-18 | Colon cancer | IC50 : >100 µM |
| dbacp02374 | Cecropin P1 | SWLSKTAKKLENSAKKRISEGIAIAIQGGPR | Small Intestine of Pig | Pore formation at the cytoplasmic membrane | MTT/MTS assay | DLD-1 | Colon cancer | IC50 : >100 µM |
| dbacp02929 | Figainin 1 | FIGTLIPLALGALTKLFK | Chaco tree frog | Membrane disruption and cell lysis | MTT/MTS assay | NIH/3T3 | Cervical cancer | IC50 : 13 µM |
| dbacp02930 | Figainin 1 | FIGTLIPLALGALTKLFK | Chaco tree frog | Membrane disruption and cell lysis | MTT/MTS assay | B16F10 | Leukemia | IC50 : 10.5 µM |
| dbacp02931 | Figainin 1 | FIGTLIPLALGALTKLFK | Chaco tree frog | Membrane disruption and cell lysis | MTT/MTS assay | MCF | Murine Melanoma | IC50 : 13.7 µM |
| dbacp02932 | Figainin 1 | FIGTLIPLALGALTKLFK | Chaco tree frog | Membrane disruption and cell lysis | MTT/MTS assay | HeLa | Breast cancer | IC50 :11.1 µM |
| dbacp02933 | Figainin 1 | MAFLKKSLFLVLFLGLVSLSIGEEEKREEEEKNEEGANQEENAENKEKRFIGTLIPLALGALTKLFKG | Chaco tree frog | Anti-proliferative action | MTT/MTS assay | NIH/3T3 | Skin cancer | IC50 : 13 µM |
| dbacp02934 | Figainin 1 | MAFLKKSLFLVLFLGLVSLSIGEEEKREEEEKNEEGANQEENAENKEKRFIGTLIPLALGALTKLFKG | Chaco tree frog | Anti-proliferative action | MTT/MTS assay | NIH/3T3 | Breast cancer | IC50 : 13 µM |
| dbacp02935 | Figainin 1 | MAFLKKSLFLVLFLGLVSLSIGEEEKREEEEKNEEGANQEENAENKEKRFIGTLIPLALGALTKLFKG | Chaco tree frog | Anti-proliferative action | MTT/MTS assay | NIH/3T3 | Cervical cancer | IC50 : 13 µM |
| dbacp02936 | Figainin 1 | MAFLKKSLFLVLFLGLVSLSIGEEEKREEEEKNEEGANQEENAENKEKRFIGTLIPLALGALTKLFKG | Chaco tree frog | Anti-proliferative action | MTT/MTS assay | B16F10 | Skin cancer | IC50 : 10.5 µM |
| dbacp02937 | Figainin 1 | MAFLKKSLFLVLFLGLVSLSIGEEEKREEEEKNEEGANQEENAENKEKRFIGTLIPLALGALTKLFKG | Chaco tree frog | Anti-proliferative action | MTT/MTS assay | B16F10 | Breast cancer | IC50 : 10.5 µM |
| dbacp02938 | Figainin 1 | MAFLKKSLFLVLFLGLVSLSIGEEEKREEEEKNEEGANQEENAENKEKRFIGTLIPLALGALTKLFKG | Chaco tree frog | Anti-proliferative action | MTT/MTS assay | B16F10 | Cervical cancer | IC50 : 10.5 µM |
| dbacp02939 | Figainin 1 | MAFLKKSLFLVLFLGLVSLSIGEEEKREEEEKNEEGANQEENAENKEKRFIGTLIPLALGALTKLFKG | Chaco tree frog | Anti-proliferative action | MTT/MTS assay | MCF | Skin cancer | IC50 : 13.7 µM |
| dbacp02940 | Figainin 1 | MAFLKKSLFLVLFLGLVSLSIGEEEKREEEEKNEEGANQEENAENKEKRFIGTLIPLALGALTKLFKG | Chaco tree frog | Anti-proliferative action | MTT/MTS assay | MCF | Breast cancer | IC50 : 13.7 µM |
| dbacp02941 | Figainin 1 | MAFLKKSLFLVLFLGLVSLSIGEEEKREEEEKNEEGANQEENAENKEKRFIGTLIPLALGALTKLFKG | Chaco tree frog | Anti-proliferative action | MTT/MTS assay | MCF | Cervical cancer | IC50 : 13.7 µM |
| dbacp02942 | Figainin 1 | MAFLKKSLFLVLFLGLVSLSIGEEEKREEEEKNEEGANQEENAENKEKRFIGTLIPLALGALTKLFKG | Chaco tree frog | Anti-proliferative action | MTT/MTS assay | HeLa | Skin cancer | IC50 : 11.1 µM |
| dbacp02943 | Figainin 1 | MAFLKKSLFLVLFLGLVSLSIGEEEKREEEEKNEEGANQEENAENKEKRFIGTLIPLALGALTKLFKG | Chaco tree frog | Anti-proliferative action | MTT/MTS assay | HeLa | Breast cancer | IC50 : 11.1 µM |
| dbacp02944 | Figainin 1 | MAFLKKSLFLVLFLGLVSLSIGEEEKREEEEKNEEGANQEENAENKEKRFIGTLIPLALGALTKLFKG | Chaco tree frog | Anti-proliferative action | MTT/MTS assay | HeLa | Cervical cancer | IC50 : 11.1 µM |
| dbacp02945 | Figainin 1 | FIGTLIPLALGALTKLFK | Skin secretions, Chaco tree frog, South America | Membrane disruption | MTT/MTS assay | NIH/3T3 | Cervical cancer | IC50 : 13 µM |
| dbacp02946 | Figainin 1 | FIGTLIPLALGALTKLFK | Skin secretions, Chaco tree frog, South America | Membrane disruption | MTT/MTS assay | B16F10 | Leukemia | IC50 : 10.5 µM |
| dbacp02947 | Figainin 1 | FIGTLIPLALGALTKLFK | Skin secretions, Chaco tree frog, South America | Membrane disruption | MTT/MTS assay | MCF | Murine melanoma | IC50 : 13.7 µM |
| dbacp02948 | Figainin 1 | FIGTLIPLALGALTKLFK | Skin secretions, Chaco tree frog, South America | Membrane disruption | MTT/MTS assay | HeLa | Breast cancer | IC50 : 11.1 µM |
| dbacp02949 | Figainin 2 | FLGAILKIGHALAKTVLPMVTNAFKPKQ | Skin secretions, Chaco tree frog, South America | Cell membrane interaction; Necrosis; Apoptosis | MTT/MTS assay | B16F10 | Murien melanoma | IC50 : 12.8 µM |
| dbacp02950 | Figainin 2 | FLGAILKIGHALAKTVLPMVTNAFKPKQ | Skin secretions, Chaco tree frog, South America | Cell membrane interaction; Necrosis; Apoptosis | MTT/MTS assay | MCF-7 | Murien melanoma | IC50 : 15.3 µM |
| dbacp02951 | Figainin 2 | MAFLKKSLFLVLFLGIVSLSVCEEEKREGEEKEEKREEEEGKEENEDGNEEHKEKRFLGAILKIGHALAKTVLPMVTNAFKPKQ | Chaco tree frog | Necrosis; Apoptosis | MTT/MTS assay | B16F10 | Skin cancer | IC50 : 12.8 µM |
| dbacp02952 | Figainin 2 | MAFLKKSLFLVLFLGIVSLSVCEEEKREGEEKEEKREEEEGKEENEDGNEEHKEKRFLGAILKIGHALAKTVLPMVTNAFKPKQ | Chaco tree frog | Necrosis; Apoptosis | MTT/MTS assay | B16F10 | Breast cancer | IC50 : 12.8 µM |
| dbacp02953 | Figainin 2 | MAFLKKSLFLVLFLGIVSLSVCEEEKREGEEKEEKREEEEGKEENEDGNEEHKEKRFLGAILKIGHALAKTVLPMVTNAFKPKQ | Chaco tree frog | Necrosis; Apoptosis | MTT/MTS assay | MCF-7 | Skin cancer | IC50 : 15.3 µM |
| dbacp02954 | Figainin 2 | MAFLKKSLFLVLFLGIVSLSVCEEEKREGEEKEEKREEEEGKEENEDGNEEHKEKRFLGAILKIGHALAKTVLPMVTNAFKPKQ | Chaco tree frog | Necrosis; Apoptosis | MTT/MTS assay | MCF-7 | Breast cancer | IC50 : 15.3 µM |
| dbacp05674 | Protein S100-A8 | MLTELEKALNSIIDVYHKYSLIKGNFHAVYRDDLKKLLETECPQYIRKKGADVWFKELDINTDGAVNFQEFLILVIKMGVAAHKKSHEESHKE | Human | Apoptosis inducing | MTT/MTS assay | MM46 | Breast cancer | IC50 : 10 µM |
| dbacp05963 | RGD-mda-7 | MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSGAQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRGDSAHRRFLLFRRAFKQLDVEAALTKALGEVDILLTWMQKFYKL | Derived from wtmda-7/IL-24 by insertion or a glycine residue between Arg(164) and Asp(165). | Apoptosis inducing | MTT/MTS assay | MCF-7 | Breast cancer | Apoptotic rate(%): >70% at concentration of 8 µg/ml |
| dbacp05964 | RGD-mda-7 | MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSGAQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAFKQL | Derived from wtmda-7/IL-24 by insertion or a glycine residue between Arg(164) and Asp(165). | Apoptosis inducing | MTT/MTS assay | Ket-3 | Tumor | Apoptotic rate(%): >50% at concentration of 8 µg/ml |
| dbacp06075 | Shiva-1 | MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG | African clawed frog | Pore formation at the cytoplasmic membrane | MTT/MTS assay | K-562 | Leukemia cancer | IC50 : 28.7 µM |
| dbacp06076 | Shiva-1 | MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG | African clawed frog | Pore formation at the cytoplasmic membrane | MTT/MTS assay | BTS-30 | Breast cancer | IC50 : 56 µM |
| dbacp06077 | Shiva-1 | MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG | African clawed frog | Pore formation at the cytoplasmic membrane | MTT/MTS assay | HRT-18 | Colon cancer | IC50 : 49.3 µM |
| dbacp06078 | Shiva-1 | MPRWRLFRRIDRVGKQIKQGILRAGPAIALVGDARAVG | African clawed frog | Pore formation at the cytoplasmic membrane | MTT/MTS assay | DLD-1 | Colon cancer | IC50 : >100 µM |
| dbacp06536 | wtmda-7/IL-24 | MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSGAQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAFKQL | Not found | Apoptosis inducing | MTT/MTS assay | MCF-7 | Breast cancer | Apoptotic rate(%) : > 50% at concentration of 8 µg/ml |
| dbacp06537 | wtmda-7/IL-24 | MNFQQRLQSLWTLARPFCPPLLATASQMQMVVLPCLGFTLLLWSQVSGAQGQEFHFGPCQVKGVVPQKLWEAFWAVKDTMQAQDNITSARLLQQEVLQNVSDAESCYLVHTLLEFYLKTVFKNYHNRTVEVRTLKSFSTLANNFVLIVSQLQPSQENEMFSIRDSAHRRFLLFRRAFKQL | Not found | Apoptosis inducing | MTT/MTS assay | Ket-3 | Tumor | Apoptotic rate(%) : > 30% at concentration of 8 µg/ml |